Modulation of type M-2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein

Citation
W. Zwerschke et al., Modulation of type M-2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein, P NAS US, 96(4), 1999, pp. 1291-1296
Citations number
44
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN journal
00278424 → ACNP
Volume
96
Issue
4
Year of publication
1999
Pages
1291 - 1296
Database
ISI
SICI code
0027-8424(19990216)96:4<1291:MOTMPK>2.0.ZU;2-I
Abstract
We report here that the E7 oncoprotein encoded by the oncogenic human papil lomavirus (HPV) type 16 binds to the glycolytic enzyme type M-2 pyruvate ki nase (M2-PK). M2-PK occurs in a tetrameric form with a high affinity to its substrate phosphoenolpyruvate and a dimeric form with a low affinity to ph osphoenolpyruvate, and the transition between both conformations regulates the glycolytic flux in tumor cells. The glycolytic intermediate fructose 1, 6-bisphosphate induces the reassociation of the dimeric to the tetrameric f orm of M2-PK. The expression of E7 in an experimental cell line shifts the equilibrium to the dimeric state despite a significant increase in the fruc tose 1,6-bisphosphate levels. Investigations of HPV-16 E7 mutants and the n ononcogenic HPV-11 subtype suggest that the interaction of HPV-16 E7 with M 2-PK may be linked to the transforming potential of the viral oncoprotein.